News & Press Releases

Integrity Applications to Present at the AMIZINO Fall 2013 Small Cap/Micro Cap Investment Conference

October 29th, 2013

Integrity Applications to Present at the AMIZINO Fall 2013 Small Cap/Micro Cap Investment Conference Press Release: Integrity Applications, Inc. – 10 hours ago RELATED QUOTES Symbol Price Change IGAP 8.50 0.00   ASHKELON, Israel–(BUSINESS WIRE)– Integrity Applications, Inc. (IGAP), developer of the GlucoTrack®model DF-F non-invasive blood glucose measurement device, announced that  Avner Gal, the Company’s […]

Read More

Archive

Sign up to our newsletter
To receive occasional news updates

LinkedIn Facebook Twitter

GlucoTrack® intended use: GlucoTrack® Model DF-F is a non-invasive intermittent glucose monitoring device for home-use. GlucoTrack® model DF-F is intended for adults 18 years and older with type 2 diabetes or pre-diabetes.

Medications intake and/or treatment decisions should not be based solely on GlucoTrack® model DF-F measurements. GlucoTrack® Model DF-F is a glucose monitoring device and should not be used for diagnosis purposes.

© 2021 Integrity Applications. All Rights Reserved.